Election of new Director

Imarex ASA has today in an Extraordinary General Meeting elected Mr. Neal B. Brady of CME Group Inc. as a new member of the Board of Directors. Mr. Brady replaces Dr. James E. Newsome, also of CME Group Inc.

Mr. Brady is Managing Director for Business Development of CME Group Inc. Imarex ASA's largest shareholder is CMEG NYMEX Holdings Inc., a company owned by CME Group Inc.

Mr. Brady was appointed Managing Director, Business Development of CME Group Inc. in August 2007.  He is responsible for the global growth of CME Group's business through strategic partnerships, investments, acquisitions and new business ventures.  In this capacity, Mr. Brady oversees new business development involving third-parties in over-the-counter (OTC)
initiatives across interest rates, foreign exchange, equities, commodities, energies and metals.

Mr. Brady's prior role, since January 2006, was as Director, Products & Services Technology, in which he was responsible for CME's market data business, Globex Account Management and technology planning and execution.

Before joining CME in 2004, Mr. Brady served as Chief Executive Officer of Liquidity Direct Technology, a trading software company he founded in 2000 and which CME acquired in January 2004.  He formerly served as head of the business strategy team for the CBOT - Eurex global electronic trading alliance (a/c/e).  Previously, he was Senior Director, Marketing and Product Development for CME and an investment officer at the International Finance Corporation (IFC) - Word Bank's Telecommunications Division. He earned a bachelor's degree cum laude in government from Harvard University, an MBA degree from Columbia Business School and Master's in International Affairs (MIA) from Columbia University's School of
International and Public Affairs.